Harvard Medical School (Boston) and the German Heart Centre (Munich) researchers led by postdoctoral researcher Nils Krger noticed that HFpEF patients enrolled in GLP-1 clinical trials were showing signs of improved symptoms and reduced clinical events
Melanotan 1 (Afamelanotide) is a 13-amino-acid linear analogue of -melanocyte-stimulating hormone (-MSH)
The combined effect is a gradual, sustained lowering of blood sugar levels
Este medicamento puede causar efectos secundarios, como nuseas/vmitos, diarrea, estreimiento, dolor abdominal, dispepsia, reacciones en el lugar de la inyeccin, fatiga, reacciones de hipersensibilidad, gases, cada del cabello, ERGE, distensin abdominal, mareos e hipotensin